bioRxiv · 20 Nov 2026
Palmitic acid overload does not promote full-blown dysfunction in SGBS adipocytes which is reflected in their secretome
S. Angelini, G. Stifani, G. La Runa, L. C. Cosenza, G. Lodi, R. Voltan, P. Secchiero, F. Castaldo, S. Gessi, S. Merighi, M. Fernandez, A. Bigot, M. Wabitsch, C. Cervellati, J. M. Sanz, A. Passaro, D. Sergi
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Background: Energy excess, and particularly long-chain saturated fatty acid (SFA) overload, are instrumental in promoting obesity and hampering metabolic health. However, SFA contribution to human adipocyte metabolic and endocrine dysfunction remains elusive. Nonetheless, we have already provided evidence that a 48-hour palmitic acid (PA) exposure is not sufficient to hamper Simpson-Golabi Behmel Syndrome (SGBS) adipocytes insulin signalling. Objective: This study aims at evaluating whether a 96-hour exposure to PA is able to disrupt SGBS adipocyte metabolic health and induce the release of a secretome capable of hampering insulin signalling in skeletal muscle cells. Methods: SGBS adipocytes were treated with either 1000 uM PA or bovine serum albumin (BSA) for 96 hours followed by the assessment of the NFkB signalling and the expression of genes associate with inflammation and adipocyte metabolic stress. Furthermore, adipocytes were labelled with BODIPY and lipid droplet as well as cell size semi-quantified using ImageJ. Insulin-induced phosphorylation of Akt and Akt substrate of 160 kDa (AS160) was assessed by Western Blot. The effect of PA on SGBS secretome was assessed by both ELISA as well as MILLIPLEX. Finally, human immortalised myotubes were co-cultured with BSA or PA-treated SGBS adipocytes for 24 hours followed by the assessment of insulin signalling at the Akt level. Results: PA did not activate the NFkB signalling pathway, but induced the expression of MCP-1 while tending to upregulate IL-6 mRNA levels. Despite 96-hour PA exposure leading to an increase in lipid droplet and cell size, this was not coupled with an impairment in insulin signalling. Nevertheless, this SFA promoted an increase in IL-6 and IL-8 secretion while tending to enhance the release of adiponectin by SGBS adipocytes. Finally, the secretome from PA-treated SGBS adipocyte did not impair insulin-induced phosphorylation of Akt relative to controls in myotubes. Conclusions: Thus, in the absence of the stromal vascular fraction, direct exposure of SGBS adipocytes to PA overload is not sufficient to elicit overt dysfunction. The absence of full-blown adipocyte dysfunction is reflected in the secretome of these cells which failed to disrupt skeletal muscle insulin signalling.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.